Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:56 AM
Ignite Modification Date:
2025-12-25 @ 4:56 AM
NCT ID:
NCT04756518
Eligibility Criteria:
Inclusion Criteria:
* Female or male participants
* Aged over 18 years old (no upper age limit)
* Patients with SARS-COV-2 positive diagnosis based on qPCR (Study COVID 19 group)
* Peripheral blood smear slides from patients with no viral infection, reposited in the laboratory slides archive within the facility prior to the emergence of COVID-19 infection in the United Kingdom (Control group)
* Peripheral blood smear slides from patients with a non-SARS-CoV-2 viral infection that were reposited in the laboratory slides archive within the facility prior to the emergence of COVID-19 infection in the United Kingdom (Control group).
Exclusion Criteria:
* Patients that are less than 18 years old
* Patients with SARS-COV-2 negative diagnosis based on qPCRPatients who have been haematological malignancies with lymphocytosis as predominant manifestation.
* Patients who have lymphopenia in the past due to underlying inflammatory disorders.
* Patients who have lymphopenia due to previous cytotoxic or immunosuppressive therapy.
* Positive diagnosis of Human Immunodeficiency Virus (HIV).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04756518
Study Brief:
Protocol Section:
NCT04756518